← Back to Clinical Trials
Recruiting NCT05582044

NCT05582044 Exercise Lower-body Negative Pressure in Heart Failure With Preserved Ejection Fraction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05582044
Status Recruiting
Phase
Sponsor University of British Columbia
Condition Heart Failure With Preserved Ejection Fraction
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2023-01-25
Primary Completion 2026-01

Trial Parameters

Condition Heart Failure With Preserved Ejection Fraction
Sponsor University of British Columbia
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 40 Years
Max Age N/A
Start Date 2023-01-25
Completion 2026-01
Interventions
Lower-body Negative Pressure (-25 mmHg)Lower-body Negative Pressure (-15 mmHg)Lower-body Neutral Pressure (0 mmHg)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The heart is a pump that must both fill and empty effectively to move blood; if it cannot move enough, heart failure may ensue. Approximately half of all adults living with heart failure have a form where the heart stiffens, which impairs its ability to fill. This form of heart failure particularly affects females and older adults. When people exercise, extra blood returns to the heart. The healthy heart can easily fill and move this extra blood to the muscles. However, when the heart's ability to fill is impaired, the extra blood can back up and pool in the lungs. Blood pooling in the lungs makes people feel breathless, although the investigators do not fully understand why, and this form of heart failure has a high risk of hospitalization and death, but few effective treatments are available. Exercise is one of the few treatments that works well if enough exercise is performed regularly. However, many people with this form of heart failure can only tolerate a small amount before stopping due to severe breathlessness, which can put them off from exercising regularly. The study's goal is to help these people perform more exercise. The investigators will use a novel form of stationary cycling with a plastic chamber around the lower body that seals at the waist. The chamber can apply suction to the lower body during exercise which will reduce how much extra blood returns and prevent the heart and lungs from being overloaded. Participants will attend 5 visits, including 3 where they will perform a submaximal exercise test for as many minutes as possible with or without light suction. In each of these tests, the investigators will record how long they exercise and ask them to rate how breathless they feel. The investigators will also study their breathing pattern, using a mouthpiece and pressure sensor, and heart function, using ultrasound imaging. This work will help adults living with heart failure exercise more and improve their health, and help researchers understand what causes breathlessness and develop new treatments.

Eligibility Criteria

Inclusion Criteria for the HFpEF Group: * Adults with a clinical diagnosis of HFpEF (LV ejection fraction ≥50%) measured in the year prior to Visit 1 (and confirmed at Visit 1), who are New York Heart Association Functional Class II-III (mild-moderate symptoms), ambulatory, receiving guideline-directed medical therapy unchanged for ≥2 months, and clinically stable for ≥3 months. * Symptom(s) of heart failure requiring treatment within the year prior to Visit 1 * NT-proBNP \>50 pmol/L (sinus rhythm) or \>150 pmol/L (atrial fibrillation in year prior) * Diastolic dysfunction based on at least one of the following echocardiographic findings: * Left atrial enlargement (diameter \>4 cm or volume index \>28 mL/m2); or * e' \<10 cm/s (lateral) or \<8 cm/s (septal), or * E/e' \>10 (lateral), or \>15 (septal) Inclusion Criteria for the Healthy Control Group: \- Healthy sedentary or recreationally active adults from the community Exclusion Criteria for the HFpEF Group: * Any prior measurement de

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology